424 related articles for article (PubMed ID: 15564499)
1. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
3. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
4. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
[TBL] [Abstract][Full Text] [Related]
5. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
6. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.
Porotto M; Fornabaio M; Greengard O; Murrell MT; Kellogg GE; Moscona A
J Virol; 2006 Feb; 80(3):1204-13. PubMed ID: 16414997
[TBL] [Abstract][Full Text] [Related]
7. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
[TBL] [Abstract][Full Text] [Related]
8. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
[TBL] [Abstract][Full Text] [Related]
9. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
10. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
Streltsov VA; Pilling P; Barrett S; McKimm-Breschkin JL
Antiviral Res; 2015 Nov; 123():216-23. PubMed ID: 26364554
[TBL] [Abstract][Full Text] [Related]
11. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
Palermo LM; Porotto M; Greengard O; Moscona A
J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
[TBL] [Abstract][Full Text] [Related]
12. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.
Porotto M; Murrell M; Greengard O; Moscona A
J Virol; 2003 Mar; 77(6):3647-54. PubMed ID: 12610140
[TBL] [Abstract][Full Text] [Related]
13. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.
Porotto M; Salah Z; DeVito I; Talekar A; Palmer SG; Xu R; Wilson IA; Moscona A
J Virol; 2012 May; 86(10):5730-41. PubMed ID: 22438532
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein.
Bousse TL; Taylor G; Krishnamurthy S; Portner A; Samal SK; Takimoto T
J Virol; 2004 Dec; 78(23):13351-5. PubMed ID: 15542686
[TBL] [Abstract][Full Text] [Related]
15. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion.
Wang Z; Mirza AM; Li J; Mahon PJ; Iorio RM
Virus Res; 2004 Feb; 99(2):177-85. PubMed ID: 14749183
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus.
Ryan C; Zaitsev V; Tindal DJ; Dyason JC; Thomson RJ; Alymova I; Portner A; von Itzstein M; Taylor G
Glycoconj J; 2006 Feb; 23(1-2):135-41. PubMed ID: 16575531
[TBL] [Abstract][Full Text] [Related]
17. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
[TBL] [Abstract][Full Text] [Related]
18. Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3.
Deng R; Mirza AM; Mahon PJ; Iorio RM
Arch Virol Suppl; 1997; 13():115-30. PubMed ID: 9413532
[TBL] [Abstract][Full Text] [Related]
19. [Study on functions of N-carbohydrate chains in human parainfluenza virus type 3 hemagglutinin-neuraminidase protein].
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang ZY
Bing Du Xue Bao; 2013 Sep; 29(5):500-8. PubMed ID: 24386838
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.
Fukushima K; Takahashi T; Ueyama H; Takaguchi M; Ito S; Oishi K; Minami A; Ishitsubo E; Tokiwa H; Takimoto T; Suzuki T
FEBS Lett; 2015 May; 589(11):1278-82. PubMed ID: 25871520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
